ENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial cancer

Simple item page
dc.contributor.authorMarth, C.
dc.contributor.authorVulsteke, C.
dc.contributor.authorRubio, M. J. R.
dc.contributor.authorMakker, V.
dc.contributor.authorBraicu, E. I.
dc.contributor.authorMcNeish, I. A.
dc.contributor.authorMadry, R.
dc.contributor.authorAyhan, A.
dc.contributor.authorHasegawa, K.
dc.contributor.authorWu, X.
dc.contributor.authorDutta, L.
dc.contributor.authorXu, C.
dc.contributor.authorKeefe, S.
dc.contributor.authorLee, J.
dc.contributor.authorPignata, S.
dc.contributor.researcherIDAAJ-5802-2021en_US
dc.date.accessioned2021-04-28T05:55:18Z
dc.date.available2021-04-28T05:55:18Z
dc.date.issued2020
dc.identifier.endpage221en_US
dc.identifier.issn0090-8258en_US
dc.identifier.startpage221en_US
dc.identifier.urihttp://hdl.handle.net/11727/5769
dc.identifier.volume159en_US
dc.identifier.wos000579556200474en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.ygyno.2020.05.366en_US
dc.relation.journalGYNECOLOGIC ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleENGOT-en9/LEAP-001: A phase III, randomized, active-controlled, open-label study of pembrolizumab plus lenvatinib versus paclitaxel plus carboplatin for newly diagnosed advanced or recurrent endometrial canceren_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos İndeksli Yayınlar Koleksiyonu
Wos Kapalı Erişimli Yayınlar